Free Trial
NASDAQ:BRTX

Biorestorative Therapies (BRTX) Stock Price, News & Analysis

Biorestorative Therapies logo
$1.45 +0.02 (+1.40%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$1.44 0.00 (-0.34%)
As of 08/8/2025 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Biorestorative Therapies Stock (NASDAQ:BRTX)

Key Stats

Today's Range
$1.38
$1.45
50-Day Range
$1.41
$2.00
52-Week Range
$1.21
$2.55
Volume
25,554 shs
Average Volume
83,726 shs
Market Capitalization
$10.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.00
Consensus Rating
Buy

Company Overview

Biorestorative Therapies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
61st Percentile Overall Score

BRTX MarketRank™: 

Biorestorative Therapies scored higher than 61% of companies evaluated by MarketBeat, and ranked 375th out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Biorestorative Therapies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Biorestorative Therapies has received no research coverage in the past 90 days.

  • Read more about Biorestorative Therapies' stock forecast and price target.
  • Earnings Growth

    Earnings for Biorestorative Therapies are expected to grow in the coming year, from ($1.43) to ($0.86) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Biorestorative Therapies is -0.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Biorestorative Therapies is -0.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Biorestorative Therapies has a P/B Ratio of 1.18. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Biorestorative Therapies' valuation and earnings.
  • Percentage of Shares Shorted

    3.15% of the float of Biorestorative Therapies has been sold short.
  • Short Interest Ratio / Days to Cover

    Biorestorative Therapies has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Biorestorative Therapies has recently decreased by 15.82%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Biorestorative Therapies does not currently pay a dividend.

  • Dividend Growth

    Biorestorative Therapies does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.15% of the float of Biorestorative Therapies has been sold short.
  • Short Interest Ratio / Days to Cover

    Biorestorative Therapies has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Biorestorative Therapies has recently decreased by 15.82%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Biorestorative Therapies this week, compared to 0 articles on an average week.
  • Search Interest

    Only 1 people have searched for BRTX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Biorestorative Therapies insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    25.50% of the stock of Biorestorative Therapies is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    69.38% of the stock of Biorestorative Therapies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Biorestorative Therapies' insider trading history.
Receive BRTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biorestorative Therapies and its competitors with MarketBeat's FREE daily newsletter.

BRTX Stock News Headlines

Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...
BioRestorative Therapies, Inc. (BRTX) - Yahoo Finance
BioRestorative Announces Share Repurchase Program
See More Headlines

BRTX Stock Analysis - Frequently Asked Questions

Biorestorative Therapies' stock was trading at $1.43 on January 1st, 2025. Since then, BRTX shares have increased by 1.4% and is now trading at $1.45.

Biorestorative Therapies, Inc. (NASDAQ:BRTX) announced its quarterly earnings data on Wednesday, May, 14th. The company reported ($0.56) earnings per share for the quarter, missing the consensus estimate of ($0.32) by $0.24. The business earned $0.03 million during the quarter, compared to analysts' expectations of $0.38 million. Biorestorative Therapies had a negative net margin of 3,093.61% and a negative trailing twelve-month return on equity of 129.47%.
Read the conference call transcript
.

Biorestorative Therapies' Board of Directors authorized a share buyback plan on Tuesday, June 17th 2025, which allows the company to repurchase $2,000,000 in shares, according to EventVestor. This means that the company could buy up to 15.9% of its shares through open market purchases. Shares buyback plans are often a sign that the company's board believes its stock is undervalued.

Shares of BRTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biorestorative Therapies investors own include NVIDIA (NVDA), Micron Technology (MU), PayPal (PYPL), Advanced Micro Devices (AMD), Avino Silver & Gold Mines (ASM), Broadcom (AVGO) and AstraZeneca (AZN).

Company Calendar

Last Earnings
5/14/2025
Today
8/08/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Healthcare
Current Symbol
NASDAQ:BRTX
CIK
1505497
Fax
N/A
Employees
7
Year Founded
N/A

Price Target and Rating

High Price Target
$18.00
Low Price Target
$18.00
Potential Upside/Downside
+1,141.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.47)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.98 million
Net Margins
-3,093.61%
Pretax Margin
-3,093.61%
Return on Equity
-129.47%
Return on Assets
-86.02%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.24
Quick Ratio
2.24

Sales & Book Value

Annual Sales
$400 thousand
Price / Sales
27.19
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.23 per share
Price / Book
1.18

Miscellaneous

Outstanding Shares
7,500,000
Free Float
5,591,000
Market Cap
$10.88 million
Optionable
Not Optionable
Beta
76.70

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:BRTX) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners